Use of a patient linked data warehouse to facilitate diabetes trial recruitment from primary care


      Recruitment into clinical trials from primary care may be difficult. Our aim was to use the Secure Anonymised Information Linkage (SAIL) databank to identify potential participants for two factitious trials. We identified 284 and 711 participants for each study (population = 250,086). This method appears promising in identifying trial participants.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Primary Care Diabetes
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Prescott R.J.
        • Counsell C.E.
        • Gillespie W.J.
        • et al.
        Factors that limit the quality, number and progress of randomised controlled trials.
        Health Technol. Assess. 1999; 3: 1-143
        • Lovato L.C.
        • Hill K.
        • Hertert S.
        • et al.
        Recruitment for controlled clinical trials: literature summary and annotated bibliography.
        Control Clin. Trials. 1997; 18: 328-352
        • Matthews D.R.
        • Kennedy E.D.
        • Darbyshire J.H.
        • Johnston D.G.
        The UK Diabetes Research Network—an opportunity and a challenge.
        Diabet. Med. 2007; 24: 7-9
        • Gale E.A.
        • Beattie S.D.
        • Hu J.
        • et al.
        Recruitment to a clinical trial improves glycemic control in patients with diabetes.
        Diab. Care. 2007; 30: 2989-2992
        • DeVries J.H.
        • Snoek F.J.
        • Kostense P.J.
        • Heine R.J.
        Improved glycaemic control in type 1 diabetes patients following participation per se in a clinical trial—mechanisms and implications.
        Diab. Metab. Res. Rev. 2003; 19: 357-362
        • Morris A.D.
        • Boyle D.I.
        • MacAlpine R.
        • et al.
        The diabetes audit and research in Tayside Scotland (DARTS) study: electronic record linkage to create a diabetes register. DARTS/MEMO Collaboration.
        BMJ. 1997; 315: 524-528
        • Owens D.R.
        • Gibbins R.L.
        • Kohner E.
        • et al.
        Diabetic retinopathy screening.
        Diabet. Med. 2000; 17: 493-494
        • Lyons R.A.
        • Jones K.H.
        • John G.
        • et al.
        The SAIL databank: linking multiple health and social care datasets.
        BMC Med. Inform. Decis. Mak. 2009; 9: 3
        • Davies H.
        • Brophy S.
        • Fielding A.
        • et al.
        Latent autoimmune diabetes in adults (LADA) in South Wales: incidence and characterization.
        Diabet. Med. 2008; 25: 1354-1357
      1. D.V. Ford, K.H. Jones, J.-P. Verplancke, et al., Data Anonymisation Policy and Process (DAPP) HIRU project document.

      2. D.V. Ford, K.H. Jones, J.-P. Verplancke, et al., The SAIL Databank: building a national architecture for e-health research and evaluation, BMC Health Serv. Res., submitted for publication.

        • Campbell M.K.
        • Snowdon C.
        • Francis D.
        • et al.
        Recruitment to randomised trials: strategies for trial enrollment and participation study. The STEPS study.
        Health Technol. Assess. 2007; 11 (iii, ix–105)
        • McDonald A.M.
        • Knight R.C.
        • Campbell M.K.
        • et al.
        What influences recruitment to randomised controlled trials? A review of trials funded by two UK funding agencies.
        Trials. 2006; 7: 9